［Presentation］TCT 2025
- 泉美 福岡
- Oct 10
- 1 min read
Prof. Terumitsu Hasebe, Director of Global Vascular Co., Ltd., will give an oral presentation at TCT 2025, the Transcatheter Cardiovascular Therapeutics annual conference, to be held in San Francisco, United States, from October 25–28, 2025.
Prof. Hasebe will present the research findings in the following session.
Presentation Information
Session Title: Novel Therapies for Peripheral Vascular Disease – 2
Date & Time: Monday, October 27, 2025, 1:00 – 2:00 PM (Pacific Time, U.S.)
Venue: Moscone Center South, Exhibition Level, Station 7 | Halls B–C, San Francisco, CA, U.S.
Presentation Title: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial
About TCT *based on information from the official CRF website
TCT, the Transcatheter Cardiovascular Therapeutics, is organized by the Cardiovascular Research Foundation (CRF) and recognized as one of the world’s leading international conferences in the field of interventional cardiovascular medicine.
Each year, experts, clinicians, and researchers from around the world gather to present and discuss the latest evidence and innovations in cardiovascular intervention.
Event Overview
Title: TCT 2025: the Transcatheter Cardiovascular Therapeutics 2025
Dates: October 25–28, 2025 (Pacific Time, U.S.)
Venue: Moscone Center (North and South Buildings), San Francisco, CA, U.S.
Organizer: Cardiovascular Research Foundation; CRF